Jatenzo Geriatric (65+): School and Activity Considerations

What Is Jatenzo and Why the Geriatric Population Needs a Separate Framework

Jatenzo is the first FDA-approved oral testosterone therapy that bypasses hepatic first-pass metabolism through lymphatic absorption. The FDA granted approval in March 2019 for adult men with hypogonadism caused by certain medical conditions. That approval label includes no upper age cutoff, but the drug's prescribing information explicitly flags that older patients may be at greater risk for adverse outcomes, particularly cardiovascular events and erythrocytosis. [1]

Men over 65 represent a distinct clinical subgroup. Testosterone levels decline roughly 1 to 2% per year after age 30, and by 65 most men have total testosterone concentrations well below the 300 ng/dL threshold the American Urological Association uses to define biochemical hypogonadism. [2] Treating that decline in older men, however, is not risk-free. The Testosterone Trials (TTrials), a coordinated set of seven placebo-controlled studies in men 65 and older (N=788), found clinically meaningful benefits in sexual function and bone density alongside a numerically higher rate of noncalcified coronary artery plaque in the testosterone arm. [3]

Why Age-Specific Activity Guidance Matters

Geriatric patients attending group fitness classes, community education programs, senior centers, or even university lifelong-learning courses face two overlapping concerns. First, Jatenzo must be taken with food containing fat, which locks the dose to mealtimes and shapes daily scheduling. Second, older adults on testosterone therapy experience transient hemodynamic changes, including blood pressure elevation, that interact with exercise intensity in ways that require planning rather than improvisation.

The Lymphatic Absorption Advantage and Its Dietary Requirement

Because Jatenzo is absorbed through intestinal lymphatics rather than the portal vein, it requires co-ingestion with dietary fat to achieve adequate exposure. The prescribing information specifies that each dose be taken with a meal or snack containing approximately 30 g of fat. [1] For a 65-year-old attending a morning fitness class, that requirement means breakfast must precede both the dose and the workout. Skipping the fat-containing meal drops bioavailability substantially and defeats the therapy.

Cardiovascular Monitoring Before and During Physical Activity

Testosterone therapy in older men raises blood pressure. In the key Jatenzo clinical trial (N=166 treated subjects), mean systolic blood pressure increased by 3.5 mmHg from baseline. [1] That number sounds modest, but in a man whose resting systolic pressure is already 135 mmHg, a 3.5 mmHg rise pushes him closer to the threshold where vigorous aerobic exercise carries additional risk.

Blood Pressure Screening Protocol

The Endocrine Society's 2018 Clinical Practice Guideline on testosterone therapy states that blood pressure should be measured before initiating therapy and at each follow-up visit in older patients. [4] For geriatric Jatenzo users who participate in structured exercise programs, HealthRX recommends blood pressure checks:

• Before starting any new exercise program
• At the 3-month dose-titration visit
• Any time systolic pressure exceeds 140 mmHg at home monitoring

Men with pre-existing hypertension should discuss whether antihypertensive adjustment is needed before adding moderate-to-vigorous physical activity to their routine.

Exercise Intensity and Heart Rate Targets

The American Heart Association recommends that older adults aim for 150 minutes per week of moderate-intensity aerobic activity or 75 minutes of vigorous activity, equivalent to roughly 50 to 70% of maximum heart rate for moderate effort. [5] Men on Jatenzo should start at the lower end of that range and advance intensity only after two consecutive blood pressure readings below 130/80 mmHg on therapy.

Resistance training is strongly encouraged. A 2019 meta-analysis in the Journal of Clinical Endocrinology and Metabolism (JCEM) covering 31 randomized trials found that testosterone therapy increased lean mass by a mean of 1.8 kg and reduced fat mass by 1.6 kg compared with placebo. [6] Those body-composition changes directly support safe, sustained participation in exercise programs for older adults.

Warning Signs That Should Stop a Workout Session

Any participant on Jatenzo who experiences chest discomfort, unexplained dyspnea, severe headache, or sudden visual change during exercise should stop immediately and seek emergency evaluation. These symptoms may represent hypertensive urgency or an acute coronary event, both of which carry elevated base rates in men over 65.

Fall Risk, Bone Density, and Why Exercise Selection Matters

Falls are the leading cause of injury-related death in adults 65 and older in the United States. The CDC reports approximately 36 million falls among older adults annually, resulting in more than 32,000 deaths. [7] Testosterone therapy may reduce fall risk through two mechanisms: increased muscle strength and improved bone mineral density.

Bone Mineral Density Data in Older Men

The TTrials Bone Trial (N=211) showed that testosterone treatment for 12 months increased volumetric bone mineral density at the lumbar spine by 7.5% and at the femoral neck by 4.9% compared with placebo (P<0.001 for both sites). [8] Those gains take months to accumulate, meaning recently initiated Jatenzo users should not assume immediate skeletal protection.

Muscle Strength and Balance

A Cochrane systematic review of testosterone in older men (23 trials, N=1,676) found modest but consistent improvements in muscle strength, with grip strength increasing by a mean of 2.4 kg over placebo. [9] Balance improvements were less consistent across trials. For this reason, older men starting Jatenzo should continue formal balance training programs (such as Tai Chi or structured physical therapy) rather than relying on testosterone alone to reduce fall risk.

Activity Selection by Fall-Risk Category

For men with a history of falls or a Timed Up and Go test score above 12 seconds, high-impact activities like jumping exercises or aggressive court sports carry elevated injury risk during the first 3 to 6 months of therapy before strength gains consolidate. Pool-based exercise, recumbent cycling, and resistance machines with back support are preferred during that window.

Scheduling Jatenzo Around Meals, Classes, and Exercise Sessions

The twice-daily dosing requirement and the fat-containing-meal rule create scheduling constraints that must be built into a geriatric patient's daily routine rather than left to chance.

Morning Dose Timing

A practical morning schedule for a patient attending a 9:00 AM fitness class might look like this:

• 7:30 AM: Breakfast with eggs, avocado, or full-fat dairy (minimum 30 g fat)
• 7:45 AM: First Jatenzo dose with breakfast
• 8:00 to 8:45 AM: Light warm-up or travel time
• 9:00 to 10:00 AM: Fitness class or structured activity

This sequence ensures the drug is absorbed before peak exercise intensity and that the patient is not exercising on an empty stomach.

Evening Dose Timing

The second daily dose should follow dinner, also with adequate dietary fat. Men who eat dinner at 5:30 PM and attend an evening lecture or community class at 7:00 PM should take their dose with dinner, not delay it until after the class. Delaying the second dose compresses the inter-dose interval and may alter serum testosterone pharmacokinetics. [1]

Classroom and Cognitive Activity Considerations

Testosterone therapy in older men shows modest positive signals for cognitive function. A sub-study of the TTrials (N=493) found that testosterone did not improve cognitive function significantly compared with placebo over 12 months, though verbal memory showed a non-significant trend toward improvement. [10] Men attending educational programs should not expect dramatic cognitive enhancement but may notice improved energy and motivation, which supports attendance and participation.

The HealthRX Geriatric Jatenzo Activity Classification Framework sorts activities into three tiers based on cardiovascular demand, fall risk, and meal-timing compatibility:

Tier 1 (Suitable from Day 1): Walking programs, seated resistance machines, water aerobics, lecture-based classroom learning, online courses, library programs.

Tier 2 (Suitable after first blood pressure confirmation at 6 to 8 weeks): Moderate cycling, light group aerobics, yoga, community garden work, golf with walking.

Tier 3 (Discuss with prescriber first): High-intensity interval training, competitive sport, vigorous hiking with elevation gain above 500 feet, activities in extreme heat above 95°F or cold below 20°F.

Erythrocytosis and Exercise Oxygen Delivery

Testosterone stimulates erythropoiesis. The Jatenzo prescribing information reports that hematocrit elevation was among the most common adverse events in clinical trials, occurring in approximately 22% of treated men. [1] Elevated hematocrit increases blood viscosity, which raises the theoretical risk of venous thromboembolism and may impair microvascular oxygen delivery during sustained aerobic exercise.

Hematocrit Monitoring Schedule

The Endocrine Society guideline recommends checking hematocrit at 3 months and 12 months after initiating testosterone therapy, then annually. [4] For geriatric patients engaged in regular aerobic exercise, HealthRX suggests checking hematocrit at the 3-month visit without exception. If hematocrit exceeds 54%, the prescribing information instructs clinicians to withhold therapy until hematocrit normalizes to a safe level. [1]

Exercise and Polycythemia Interaction

A man with hematocrit above 52% exercising at moderate intensity in warm conditions faces compounded risk from dehydration-driven hemoconcentration. Geriatric Jatenzo users should prioritize hydration before, during, and after exercise sessions, targeting at least 500 mL of water in the two hours preceding activity.

Prostate Health Monitoring for Active Older Men

The FDA-approved labeling for Jatenzo includes a warning regarding potential stimulation of prostate tissue. [1] Men 65 and older already carry a substantially higher baseline risk of prostate cancer. The American Cancer Society reports that approximately 60% of all prostate cancer diagnoses occur in men over 65. [11]

PSA Monitoring Schedule

The Endocrine Society recommends measuring prostate-specific antigen (PSA) before initiating testosterone therapy in men over 40 and re-checking at 3 to 6 months and then annually. [4] A PSA rise of more than 1.4 ng/mL above baseline within any 12-month period, or an absolute PSA above 4.0 ng/mL, warrants urology referral before continuing therapy or advancing activity programs. [4]

Lower Urinary Tract Symptoms and Activity

Older men with lower urinary tract symptoms (LUTS), including urinary urgency or frequency, may find high-impact exercise uncomfortable. Jatenzo does not directly worsen LUTS in most patients, but testosterone-driven prostate volume changes over months of therapy may affect urinary flow. Men reporting new or worsening LUTS should have a uroflow assessment before continuing vigorous activity programs.

Drug Interactions That Affect Exercise Safety

Jatenzo interacts with several drug classes commonly prescribed to older adults. These interactions carry direct implications for exercise safety.

Anticoagulants

Testosterone can potentiate the effect of warfarin. A 2015 systematic review published in JAMA Internal Medicine (covering 39 studies) found that testosterone therapy was associated with increased anticoagulant effect in warfarin users. [12] Older men on warfarin who begin Jatenzo and then start a new exercise program should have INR checked within 2 weeks, as both exercise-related dietary changes and testosterone itself can shift anticoagulant response.

Insulin and Antidiabetic Agents

Testosterone improves insulin sensitivity. A randomized controlled trial published in Diabetes Care (N=178, 52 weeks) found that testosterone undecanoate injection reduced HbA1c by 0.5% compared with placebo in men with type 2 diabetes and hypogonadism. [13] For geriatric men on insulin or sulfonylureas, that improved sensitivity may increase hypoglycemia risk during exercise. Glucose checks before and after activity sessions are reasonable for the first 4 to 6 weeks on Jatenzo.

Corticosteroids

Chronic corticosteroid use is common in older adults with inflammatory conditions. Corticosteroids antagonize some anabolic effects of testosterone and independently raise cardiovascular risk. Men on prednisone 10 mg/day or above should discuss individualized exercise intensity caps with their prescriber before enrolling in structured fitness programs alongside Jatenzo therapy.

Social and Educational Program Participation

Men 65 and older often attend senior centers, community colleges, hospital wellness programs, or faith-based fitness classes. These environments offer physical activity alongside cognitive and social engagement, all of which independently support healthy aging. Testosterone therapy may improve energy and mood, supporting sustained attendance. A randomized trial published in the Journal of Clinical Endocrinology and Metabolism found that testosterone improved self-reported energy in hypogonadal men over 65 within 3 months of treatment initiation. [14]

Transportation and Timing Logistics

Men who rely on public transportation or scheduled shuttle services to reach classes must build meal timing into their transit schedule. A man taking a 10:00 AM community college class who catches a bus at 9:15 AM needs to eat his fat-containing breakfast and first Jatenzo dose by 9:00 AM at the latest. Waiting to eat at the class venue is not a reliable strategy, as cafeteria availability may not guarantee adequate fat content.

Heat Exposure During Outdoor Activities

Summer outdoor activities at senior programs carry dehydration risk, which compounds erythrocytosis risk on Jatenzo. Men should avoid outdoor activity during peak heat hours (10:00 AM to 4:00 PM in summer) and wear moisture-wicking clothing. A study in the British Journal of Sports Medicine reported that older adults experience impaired thermoregulation during exercise in ambient temperatures above 30°C (86°F), with heart rate and core temperature rising faster than in younger adults. [15]

Social Engagement and Adherence

Group-based exercise programs improve medication adherence in older adults. A 2020 cohort study in the Journal of the American Geriatrics Society found that participation in structured group activity was associated with 23% higher medication adherence rates over 12 months compared with solitary home exercise. [16] Recommending that geriatric Jatenzo patients join group fitness or educational programs is therefore not just quality-of-life advice. It directly supports consistent dosing.